Compare · OBIO vs PM
OBIO vs PM
Side-by-side comparison of Orchestra BioMed Holdings Inc. (OBIO) and Philip Morris International Inc (PM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OBIO and PM operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $259.31B, about 1090.8x OBIO ($237.7M).
- Over the past year, OBIO is up 44.0% and PM is down 2.6% - OBIO leads by 46.6 points.
- PM has been more active in the news (14 items in the past 4 weeks vs 6 for OBIO).
- PM has more recent analyst coverage (25 ratings vs 9 for OBIO).
- Company
- Orchestra BioMed Holdings Inc.
- Philip Morris International Inc
- Price
- $3.94-1.00%
- $166.45+0.75%
- Market cap
- $237.7M
- $259.31B
- 1M return
- -9.10%
- +5.79%
- 1Y return
- +43.98%
- -2.59%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 6
- 14
- Recent ratings
- 9
- 25
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest OBIO
- FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
- Amendment: SEC Form SCHEDULE 13D/A filed by Orchestra BioMed Holdings Inc.
- Large owner Rtw Investments, Lp exercised 1,250,032 in-the-money shares at a strike of $0.00 and sold $132 worth of shares (32 units at $4.13) (SEC Form 4)
- SEC Form DEFA14A filed by Orchestra BioMed Holdings Inc.
- SEC Form DEF 14A filed by Orchestra BioMed Holdings Inc.
- Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
- SEC Form 4 filed by Sherman Darren
- SEC Form 4 filed by Aiello Joshua
- SEC Form 4 filed by Hochman David P
- Officer Hochman David P bought $42,900 worth of shares (10,000 units at $4.29), increasing direct ownership by 0.93% to 1,086,467 units (SEC Form 4)
Latest PM
- Philip Morris International Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Philip Morris International to Host Webcast of 2026 Virtual Annual Meeting of Shareholders
- SEC Form FWP filed by Philip Morris International Inc
- SEC Form 10-Q filed by Philip Morris International Inc
- Philip Morris International Expands its Partnership with Ducati Corse as Decades-Long Partnership Races Forward with Purpose
- Philip Morris International Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Philip Morris International Reports 2026 First-Quarter Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only;
- IQOS and Devialet Introduce "Soundsorial Design" Collaboration
- Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
- PMI U.S. Calls for Science‑Based Policy and Credible, Open Dialogue to Accelerate America's Smoke‑Free Future